Managed alcohol programs for Indigenous Peoples in Canada: A scoping review
PLOS Mental Health · 14.07.2026 · 3 (7) · e0000651
DOI: 10.1371/journal.pmen.0000651 ↗Kurz gefasst
Scoping Review in der Zeitschrift PLOS Mental Health, online erschienen am 14.07.2026. Verfasst von Madyson Campbell und 5 weiteren Autor:innen. Beteiligte Einrichtung: Northern Ontario School of Medicine University, Sudbury, Ontario, Canada. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 36 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Northern Ontario Academic Medicine Association.
Abstract (Originalsprache)
Managed Alcohol Programs (MAPs), provide regulated access to beverage alcohol alongside housing and health and social supports for individuals with severe AUD and chronic homelessness. While evidence for MAP effectiveness is growing, less is known about their implementation and impact within Indigenous and geographically remote contexts. We conducted a scoping review following PRISMA guidelines evaluate the literature on MAPs operating in Indigenous, northern, rural, and remote communities. A comprehensive search of PubMed, Embase, PsycINFO, and CINAHL was completed in July 2025, supplemented by grey literature and reference list screening. Studies were eligible if they described programs that regulated alcohol consumption for individuals experiencing homelessness and AUD within Indigenous or geographically remote contexts. Two reviewers independently screened articles, and data were extracted using a standardized form. Of 264 records identified, 13 studies met inclusion criteria. Programs were located primarily in Canada, with additional sites in Australia and the United States. Four key themes emerged: (1) integration of Indigenous cultural knowledge and healing practices; (2) housing stability and the creation of “home” within MAPs; (3) reductions in alcohol-related harms, including decreased non-beverage alcohol use and acute healthcare utilization; and (4) barriers and facilitators to implementation. Indigenous-led and culturally grounded MAPs emphasized self-determination, Elders’ involvement, and land- and culture-based healing. Participation in MAPs was consistently associated with improved housing security, safer drinking environments, and reduced health and social harms. However, implementation challenges included stigma, funding instability, and infrastructure limitations in remote settings. MAPs appear to offer a promising, culturally adaptable harm reduction approach for individuals with severe AUD in Indigenous and geographically underserved communities. Indigenous leadership, cultural integration, and community-driven design are critical to program acceptability and sustainability. Further research is needed to evaluate long-term health outcomes and to expand evidence in northern, rural, and remote contexts.
Autor:innen und Institutionen
- Northern Ontario School of Medicine University, Sudbury, Ontario, Canada.
- Health Science North, Sudbury, Ontario, Canada.
- Laurentian University, Sudbury, Ontario, Canada.
ORCID-Profile: Madyson Campbell, David C Marsh
Förderung
- Northern Ontario Academic Medicine Association
Zitieren
APA
Campbell, M., Morin, K. A., Marsh, T. N., Harrison, S. L., Labrosse, D. S., & Marsh, D. C. (2026). Managed alcohol programs for Indigenous Peoples in Canada: A scoping review. PLOS Mental Health, 3(7), e0000651. https://doi.org/10.1371/journal.pmen.0000651
Vancouver
Campbell M, Morin KA, Marsh TN, Harrison SL, Labrosse DS, Marsh DC. Managed alcohol programs for Indigenous Peoples in Canada: A scoping review. PLOS Mental Health. 2026;3(7):e0000651. doi:10.1371/journal.pmen.0000651
BibTeX
@article{Campbell2026,
author = {Campbell, Madyson and Morin, Kristen A and Marsh, Teresa N and Harrison, Sarah L and Labrosse, Danielle S and Marsh, David C},
title = {Managed alcohol programs for Indigenous Peoples in Canada: A scoping review},
journal = {PLOS Mental Health},
year = {2026},
volume = {3},
number = {7},
pages = {e0000651},
doi = {10.1371/journal.pmen.0000651}
}
EUVIMED